Kabra Drugs informs about disclosure

13 Dec 2019 Evaluate

Kabra Drugs has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shyam Kabra.

The above information is a part of company’s filings submitted to BSE.


Kabra Drugs Share Price

7.54 0.00 (0.00%)
03-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1455.00
Dr. Reddys Lab 5730.85
Cipla 1459.75
Zydus Lifesciences 1007.20
Lupin 1564.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.